Form 4: Abbott Laboratories Executive Vice President Reports Stock Disposal

Robert E. Funck, Jr., Executive Vice President of Abbott Laboratories, reports the disposal of 11,415 common shares to cover tax obligations.

Summary

• Robert E. Funck, Jr., an Executive Vice President at Abbott Laboratories, filed a Form 4 with the SEC.
• The report details a transaction on February 29, 2024, where 11,415 common shares were disposed of at a price of $120.05 per share.
• This disposal was likely to cover tax obligations related to vesting of stock awards.
• Following the transaction, Funck directly owns 211,341 common shares.
• He also has indirect ownership through a daughter's annual gift trust (20,000 shares), the Abbott Laboratories Stock Retirement Trust (18,765 shares), and shares held by his daughter (500 shares).
• Funck disclaims beneficial ownership of shares held by his daughter and the trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a stock transaction by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates that an executive vice president at Abbott Laboratories disposed of shares, which is a common occurrence for executives managing their personal portfolios and tax obligations.

Key Dates